期刊文献+

DRG支付下IF55病种医用耗材应用现状与对策研究

Application Status and Countermeasures of IF55 Medical Consumables under DRG Payment
下载PDF
导出
摘要 目的统计某院IF55病种患者医用耗材应用情况,分析存在问题,提出改进建议。方法对2022年入组到IF55病种的137例住院患者的病历进行回顾性分析,应用SPSS 22.0软件统计分析医用耗材应用情况。结果IF55病种耗材费占总费用的48.75%,应用敷料、冲洗、缝合器/线未显著缩短患者住院天数(P均>0.05),应用电极未有效减少术中出血量(P>0.05),且骨质材料使用指征不明确,病历书写不规范。结论该院IF55病种患者医用耗材使用存在占比高、品类多、使用指征不严格、使用随意等问题。医院应规范耗材使用目录,完善临床管理制度,应用信息化手段提升管理效能。 Objective To analyze the application of medical consumables for IF55 patients in a hospital,the existing problems,and put forward suggestions for improvement.Methods The medical records of 137 hospitalized patients with IF55 diseases in 2022 were retrospectively analyzed,and the application of medical consumables was statistically analyzed by SPSS 22.0 software.Results The cost of IF55 disease consumables accounted for 48.75%of the total cost.The application of dressing,irrigation,and suture consumables did not significantly shorten the length of hospital stay of patients(P>0.05),the application of electrodes did not effectively reduce the amount of intraoperative blood loss(P>0.05),and the indications for the use of bone materials were unclear,and the medical records were not standardized.Conclusion The use of medical consumables in IF55 patients in our hospital has some problems,such as high proportion,many categories,not strict indication and arbitrary use.Hospitals should standardize the use of consumables catalogue,improve the clinical management system,and apply information means to improve management efficiency.
作者 魏巍 孙明 徐茂云 WEI Wei;SUN Ming;XU Maoyun(不详;960th Hospital of PLA,Jinan,Shandong,250031,China)
出处 《中国卫生质量管理》 2023年第12期28-32,共5页 Chinese Health Quality Management
基金 解放军第九六〇医院2023年青年创新科学基金——基于已有DRG分组诊疗数据知识库引导实时分组管理(编号:2023FY01)。
关键词 DRG IF55病种 医用耗材 成本管理 Diagnostic Related Group IF55 Diseases Medical Consumables Cost Management
  • 相关文献

参考文献11

二级参考文献117

  • 1宋国玉,谢丽娜.三级公立医院应对DRGs付费的运营管理思考[J].纳税,2021,15(36):134-136. 被引量:3
  • 2李小瑜,狄雪平.DRGs付费方式下的公立医院成本管理[J].财经界,2021(15):185-186. 被引量:5
  • 3[12]Swenson CL,Arnoczky SP.Demineralization for inactivation of infectious retrovirus in systemically infected cortical bone:in vitro and in vivo experimental studies.J Bone Joint Surg Am.2003,85-A (2):323-32. 被引量:1
  • 4[13]Fleming JE Jr,Cornell CN,Muschler GF.Bone cells and matrices in orthopedic tissue engineering.Orthop Clin North Am.2000,31 (3):357-74. 被引量:1
  • 5[14]Cornell CN.Osteoconductive materials and their role as substitutes for autogenous bone grafts.Orthop Clin North Am.1999,30 (4):591-8. 被引量:1
  • 6[15]Holmes RE.Bone regeneration within a coralline hydroxyapatite implant.Plast Reconstr Surg.1979,63 (5):626-33. 被引量:1
  • 7[16]Havelin LI,Engesaeter LB,Espehaug B,et al.The Norwegian Arthroplasty Register:11 years and 73,000 arthroplasties.Acta Orthop Scand.2000,71 (4):337-53. 被引量:1
  • 8[17]Thomas DB,Brooks DE,Bice TG,et al.Tobramycin-impregnated calcium sulfate prevents infection in contaminated wounds.Clin Orthop Relat Res.2005,441:366-71. 被引量:1
  • 9[18]Williams JA,Billington RW.Increase in compressive strength of glass ionomer restorative materials with respect to time:a guide to their suitability for use in posterior primary dentition.J Oral Rehabil.1989,16 (5):475-9. 被引量:1
  • 10[19]Jonck LM,Grobbelaar CJ.Ionos bone cement (glass-ionomer):an experimental and clinical evaluation in joint replacement.Clin Mater.1990,6 (4):323-59. 被引量:1

共引文献75

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部